Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -173

Accepted - Volume 3

Comment Record
Commentor Mr. Gregory Patch Date/Time 2002-11-05 19:33:53
Organization Berkshire Mountains Herb Company
Category Company

Comments for FDA General
Questions
1. General Comments I oppose the study of Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5. There must be sound scientific proof that this will not harm the child's natural process of growth. The pre human testing must also show scientifically that ill side effects will not occur in generations to follow.




EC -173